Kheiron Medical Technologies, a startup that aims to help radiologists detect breast cancer earlier by using deep learning, has announced this week the closing of a $22m Series A round led by London-headquartered VC firm Atomico. Connect Ventures, Greycroft, Hoxton Ventures and EXOR Seeds, existing backers, also participated. The startup was founded in 2016 by Peter Kecskemethy and Tobias Rijken, and its first product, called Mia (Mammography Intelligent Assessment), was created to help improve outcomes for the millions of women living with breast cancer globally. It is designed to analyse standard full-field digital mammography (FFDM) images in a breast cancer screening setting and support radiologists in making the clinical decision to recall a patient for further investigation or not. "In my childhood I spent many hours in my mother's radiology department watching her carefully read and report imaging studies and struggling with workloads and working conditions," said Dr Peter Kecskemethy, chief executive of Kheiron.